Mitochondrial DNA an endogenous trigger for immune paralysis

Anesthesiology

Volumn 124, Issue 4, 2016, Pages 923-933

  Schäfer, Simon T ^a   Franken, Lars ^b   Adamzik, Michael ^a,c   Schumak, Beatrix ^b   Scherag, André ^d   Engler, Andrea ^a   Schönborn, Niels ^a   Walden, Jennifer ^a   Koch, Susanne ^b   Baba, Hideo A ^a   Steinmann, Jörg ^a   Westendorf, Astrid M ^a   Fandrey, Joachim ^e   Bieber, Thomas ^b   Kurts, Christian ^b   Frede, Stilla ^e,f   Peters, Jürgen ^a   Limmer, Andreas ^b,f  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 6; ADENOVIRUS VECTOR; INDOLEAMINE 2,3 DIOXYGENASE; MITOCHONDRIAL DNA; OVALBUMIN; PROGRAMMED DEATH 1 LIGAND 1; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPARALYSIS; MAJOR CLINICAL STUDY; MITOCHONDRIAL GENE; MORTALITY; MOUSE; NONHUMAN; OBSERVATIONAL STUDY; PARALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; SEPSIS; SPLEEN INJURY; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; CRITICAL ILLNESS; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; IMMUNITY; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; AGED; ANIMALS; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEPSIS;

EID: 84955572184     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000001008     Document Type: Article

References (43)

1. Prass K, Meisel C, Höfich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A: Stroke-induced immunodefciency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198:725-36
2. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA: Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 2006; 176:225-36
3. Ward PA: What's new in the quagmire of sepsis? Trends Mol Med 2014; 20:189-90
4. Vincent JL, Opal SM, Marshall JC, Tracey KJ: Sepsis defni-tions: Time for change. Lancet 2013; 381:774-5
5. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH, Cobb JP, Coopersmith C, Karl IE: Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 2002; 168:2493-500
6. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD II, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011; 306:2594-605
7. Boomer JS, Green JM, Hotchkiss RS: The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer? Virulence 2014; 5:45-56
8. Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, Pachot A, Brooks TL, Deych E, Shannon WD, Green JM, Storch GA, Hotchkiss RS: Reactivation of multiple viruses in patients with sepsis. PLoS One 2014; 9:e98819
9. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-50
10. Schäfer ST, Gessner S, Scherag A, Rump K, Frey UH, Siffert W, Westendorf AM, Steinmann J, Peters J, Adamzik M: Hydrocortisone fails to abolish NF-κB1 protein nuclear trans-location in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins/delATTG) and is associated with increased 30-day mortality in septic shock. PLoS One 2014; 9:e104953
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39:165-228
12. Schwandt T, Schumak B, Gielen GH, Jüngerkes F, Schmidbauer P, Klocke K, Staratschek-Jox A, van Rooijen N, Kraal G, Ludwig-Portugall I, Franken L, Wehner S, Kalff JC, Weber O, Kirschning C, Coch C, Kalinke U, Wenzel J, Kurts C, Zawatzky R, Holzmann B, Layland L, Schultze JL, Burgdorf S, den Haan JM, Knolle PA, Limmer A: Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. EMBO J 2012; 31:201-13
13. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA: The sepsis seesaw: Tilting toward immunosuppression. Nat Med 2009; 15:496-7
14. Schäfer ST, Frede S, Winning S, Bick A, Roshangar P, Fandrey J, Peters J, Adamzik M: Hypoxia-inducible factor and target gene expression are decreased in patients with sepsis: Prospective observational clinical and cellular studies. Anesthesiology 2013; 118:1426-36
15. Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A: The new normal: Immunomodulatory agents against sepsis immune suppression. Trends Mol Med 2014; 20:224-33
16. Dalod M: Professional cross-presenting CD8α-type CD141(hi) dendritic cells: We have got you in our skin! Immunity 2012; 37:3-5
17. Sparwasser T, Miethke T, Lipford G, Borschert K, Häcker H, Heeg K, Wagner H: Bacterial DNA causes septic shock. Nature 1997; 386:336-7
18. Adamzik M, Schäfer S, Frey UH, Becker A, Kreuzer M, Winning S, Frede S, Steinmann J, Fandrey J, Zacharowski K, Siffert W, Peters J, Hartmann M: The NFKB1 promoter polymorphism (-94ins/delATTG) alters nuclear translocation of NF-κB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis. Anesthesiology 2013; 118:123-33
19. Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13:260-8
20. Wingender G, Garbi N, Schumak B, Jüngerkes F, Endl E, von Bubnoff D, Steitz J, Striegler J, Moldenhauer G, Tüting T, Heit A, Huster KM, Takikawa O, Akira S, Busch DH, Wagner H, Hämmerling GJ, Knolle PA, Limmer A: Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur J Immunol 2006; 36:12-20
21. Tschiedel E, Steinmann J, Buer J, Onnebrink JG, Felderhoff-Müser U, Rath PM, Dohna-Schwake C: Results and relevance of molecular detection of pathogens by SeptiFast-A retrospective analysis in 75 critically ill children. Klin Padiatr 2012; 224:12-6
22. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause infammatory responses to injury. Nature 2010; 464:104-7
23. Fernández-Ruiz I, Arnalich F, Cubillos-Zapata C, Hernández-Jiménez E, Moreno-González R, Toledano V, Fernández-Velasco M, Vallejo-Cremades MT, Esteban-Burgos L, de Diego R P, Llamas-Matias MA, García-Arumi E, Martí R, Boscá L, Andreu AL, López-Sendón JL, López-Collazo E: Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: An observation in patients with myocardial infarction. PLoS One 2014; 9:e95073
24. Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, Lawler LA, Christie JD, Meyer NJ, Mc Causland FR, Waikar SS, Waxman AB, Chung RT, Bueno R, Rosas IO, Fredenburgh LE, Baron RM, Christiani DC, Hunninghake GM, Choi AM: Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: Derivation and validation. PLoS Med 2013; 10:e1001577; discussion e1001577
25. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Defnitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55
26. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5
27. Frezza C, Cipolat S, Scorrano L: Organelle isolation: Functional mitochondria from mouse liver, muscle and cultured fbroblasts. Nat Protoc 2007; 2:287-95
28. Backer R, Schwandt T, Greuter M, Oosting M, Jüngerkes F, Tüting T, Boon L, O'Toole T, Kraal G, Limmer A, den Haan JM: Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells. Proc Natl Acad Sci USA 2010; 107:216-21
29. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR: Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997; 186:239-45
30. Gosiewski T, Flis A, Sroka A, Kedzierska A, Pietrzyk A, Kedzierska J, Drwiła R, Bulanda M: Comparison of nested, multiplex, qPCR; FISH; SeptiFast and blood culture methods in detection and identifcation of bacteria and fungi in blood of patients with sepsis. BMC Microbiol 2014; 14:313
31. Wherry EJ, Teichgräber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R: Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225-34
32. Pardoll DM: The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252-64
33. Hotchkiss RS, Monneret G, Payen D: Sepsis-induced immu-nosuppression: From cellular dysfunctions to immunother-apy. Nat Rev Immunol 2013; 13:862-74
34. Chang KC, Burnham CA, Compton SM, Rasche DP, Mazuski RJ, McDonough JS, Unsinger J, Korman AJ, Green JM, Hotchkiss RS: Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Crit Care 2013; 17:R85
35. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443-54
36. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191-3
37. von Bergwelt-Baildon MS, Popov A, Saric T, Chemnitz J, Classen S, Stoffel MS, Fiore F, Roth U, Beyer M, Debey S, Wickenhauser C, Hanisch FG, Schultze JL: CD25 and indole-amine 2, 3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: Additional mechanisms of T-cell inhibition. Blood 2006; 108:228-37
38. Niño-Castro A, Abdullah Z, Popov A, Thabet Y, Beyer M, Knolle P, Domann E, Chakraborty T, Schmidt SV, Schultze JL: The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes. Innate Immun 2014; 20:401-11
39. Mittal R, Coopersmith CM: Redefning the gut as the motor of critical illness. Trends Mol Med 2014; 20:214-23
40. Marshall JC: Why have clinical trials in sepsis failed? Trends Mol Med 2014; 20:195-203
41. Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med 2008; 14:64-78
42. Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 1997; 3:678-81
43. Fernández-Ruiz M, Kumar D, Humar A: Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clin Transl Immunol 2014; 3:e12